참고문헌
- Ashibara K, Saito T, Mizumoto H, et al (2002). Mutation of beta-catenin gene in endometrialcancer but not in associated hyperplasis. Med Electron Microsc, 35, 9-15. https://doi.org/10.1007/s007950200001
- Daa T, Kashima K, Kaku N, et al (2004). Mutations in components of the Wnt signaling pathway in adenoid cystic carcinoma. Mod Pathol, 17, 1475-82. https://doi.org/10.1038/modpathol.3800209
- Hasegawa T, Yokoyama R, Matsuno Y, et al (2001). Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol, 32, 257-63. https://doi.org/10.1053/hupa.2001.22764
- Hino S, Michiue T, Asashima M, et al (2003). Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin. J Biol Chem, 278, 14066-73. https://doi.org/10.1074/jbc.M213265200
- Jin L H, Shao QJ, Luo W, et al (2003). Detection of point mutations of the Axin1 gene in colorectal cancers. Int J Cancer, 107, 696-9. https://doi.org/10.1002/ijc.11435
- Karim R, Tse G, Putti T, et al (2004). The significance of the Wnt pathway in the patho-logy of human cancers. Pathology, 369, 120-8.
- Kikuchi A (1999). Roles of Axin in the Wnt signalling pathway. Cell Signal, 11, 777-88. https://doi.org/10.1016/S0898-6568(99)00054-6
- Liu C, Li Y, Semenov M, et al (2002). Control of beta-catenin phosphorylation/degradation by a Dual-kinase mechanism. Cell, 108, 837-47. https://doi.org/10.1016/S0092-8674(02)00685-2
- Luo W, Lin SC (2004). Axin: a master scaffold for multiple signaling pathways. Neurosignals, 13, 99-113. https://doi.org/10.1159/000076563
- Nakajima M, Fukuchi M, Miyazaki T, et al (2003). Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer, 88, 1734-9. https://doi.org/10.1038/sj.bjc.6600941
- Neo SY, Zhang Y, Yaw LP, et al (2000). Axin-induced apoptosis depends on the extent of its JNK activation and its ability to down-regulate beta-catenin leveks. Biochem Biophys Res Commun, 272, 144-50. https://doi.org/10.1006/bbrc.2000.2751
-
Pirinen RT, Hirvikoski P, Johansson RT, et al (2001). Reduced expression Of
$\alpha$ -catenin,$\beta$ -catenin, and$\gamma$ -catenin is associated with high cell proliferative activity and poor differentiation in nonsmall cell lung cancer. J Clin Pathol, 54, 391-5. https://doi.org/10.1136/jcp.54.5.391 -
Rubinfeld B, Robbins P, EL-Gamil M, et al (1997). Stailization of
$\beta$ -catenin by genetic defects in melanoma cell line. Science, 275, 1790-2. https://doi.org/10.1126/science.275.5307.1790 - Rui Y, Xu Z, Lin S, et al (2004). Axin stimulates p53 functions by activation of HIPK2 kinase through Multimeric complex formation. EMBO J, 23, 4583-94. https://doi.org/10.1038/sj.emboj.7600475
- Satoh S, Daigo Y, Furukawa Y, et al (2000). AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet, 24, 245-50. https://doi.org/10.1038/73448
- Takahashi M, Tsunoda T, Seiki M, et al (2002). Identification Of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene, 21, 5861-7. https://doi.org/10.1038/sj.onc.1205755
- Ueta T, Ikeguchi M, Hirooka Y, et al (2002). Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma. Oncol Rep, 9, 1197-203.
- Zeng L, Fagotto F, Zhang T, et al (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell, 90, 181-92. https://doi.org/10.1016/S0092-8674(00)80324-4
- Zeng L, Fagotto F, Zhang T, et al (1997). The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axin formation. Cell, 90, 181-92. https://doi.org/10.1016/S0092-8674(00)80324-4
피인용 문헌
- Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells vol.30, pp.3, 2013, https://doi.org/10.3892/or.2013.2560
- MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells vol.10, pp.5, 2014, https://doi.org/10.3892/mmr.2014.2526
- Prognostic Significance of Beta-Catenin Expression in Patients with Esophageal Carcinoma: a Meta-analysis vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6103
- PKM2 Regulates Hepatocellular Carcinoma Cell Epithelial-mesenchymal Transition and Migration upon EGFR Activation vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.1961
- Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis vol.9, pp.11, 2014, https://doi.org/10.1371/journal.pone.0111885
- Serum Biomarkers for Early Detection of Hepatocellular Carcinoma Associated with HCV Infection in Egyptian Patients vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1281
- Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3536
- Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway vol.17, pp.1, 2017, https://doi.org/10.1186/s12866-017-1032-4
- A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland vol.9, pp.2, 2017, https://doi.org/10.3390/cancers9020014